|
Re: ZHCLF
|
1
|
Zenith Epigenetics
|
Jul 26, 2022 06:41AM
|
|
Re: HOW LONG
|
2
|
Resverlogix Corp.
|
Jul 27, 2022 09:32PM
|
|
Re: Bank value of your shares
|
2
|
Zenith Epigenetics
|
Aug 01, 2022 02:45PM
|
|
Re: Thrown in the towel?
|
5
|
Resverlogix Corp.
|
Aug 02, 2022 11:25AM
|
|
Re: Thrown in the towel?
|
7
|
Resverlogix Corp.
|
Aug 04, 2022 03:26PM
|
|
Re: Also interesting, but less encouraging
|
3
|
Resverlogix Corp.
|
Aug 05, 2022 07:09AM
|
|
Re: Also interesting, but less encouraging
|
7
|
Resverlogix Corp.
|
Aug 05, 2022 08:53PM
|
|
Re: Also interesting, but less encouraging
|
6
|
Resverlogix Corp.
|
Aug 06, 2022 09:11PM
|
|
Re: FDA meeting
|
3
|
Resverlogix Corp.
|
Aug 09, 2022 08:50AM
|
|
Re: FDA meeting
|
3
|
Resverlogix Corp.
|
Aug 09, 2022 01:22PM
|
|
Re: FDA meeting
|
4
|
Resverlogix Corp.
|
Aug 09, 2022 03:31PM
|
|
Re: Dr. Wong retires - Dr. Kulikowski in as CSO
|
3
|
Resverlogix Corp.
|
Aug 16, 2022 06:11AM
|
|
Re: Dr. Wong retires - Dr. Kulikowski in as CSO
|
4
|
Resverlogix Corp.
|
Aug 16, 2022 10:45AM
|
|
Re: Kausik Ray tweeted this this morning
|
4
|
Resverlogix Corp.
|
Aug 18, 2022 12:48PM
|
|
Approval of First ‘Epigenetic’ Drug for a Solid Tumor: January 31, 2020
|
2
|
Resverlogix Corp.
|
Aug 18, 2022 08:14PM
|
|
Re: Resverlogix Publishes New Data Highlighting Apabetalone’s Benefit in Non-alcoholic Fatty Liver Disease
|
12
|
Resverlogix Corp.
|
Aug 22, 2022 09:48AM
|
|
Re: Looking forward now , can/will management use this meeting as the start of many positive updates?
|
2
|
Resverlogix Corp.
|
Aug 25, 2022 02:18PM
|
|
Re: Looking forward now , can/will management use this meeting as the start of many positive updates?
|
4
|
Resverlogix Corp.
|
Aug 29, 2022 08:21AM
|
|
Re: Looking forward now , can/will management use this meeting as the start of many positive updates?
|
3
|
Resverlogix Corp.
|
Aug 30, 2022 08:08PM
|
|
Re: Zacks BTI Valuation
|
1
|
BIOASIS TECHNOLOGIES INC
|
Aug 31, 2022 07:47AM
|
